(S) -2-N-propylamino-5-hydroxytetralin as a D3 agonistic therapeutic
- 专利权人:
- ウーツェーベー ファルマ ゲーエムベーハー
- 发明人:
- ディーター シェラー,クラウス ハンゼン
- 申请号：
- JP2006544295
- 公开号：
- JP5253737B2
- 申请日:
- 2004.12.13
- 申请国别(地区):
- JP
- 年份:
- 2013
- 代理人:
- 摘要：
- The invention relates to a medicament containing (S)-2-N-propylamino-5-hydroxytetralin, the salts or prodrugs thereof. As a D3 agonist, (S)-2-N-propylamino-5-hydroxytetralin is suitable particularly for the treatment of dopa-sensitive movement disorders.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- (S)-2-N-propylamino-5-hydroxytetralin as a D3-agonist
- (S)-2-N-PROPYLAMINO-5-HYDROXYTETRALINE UTILISEE COMME AGENT THERAPEUTIQUE AYANT UN EFFET AGONISTE SUR LE RECEPTEUR D3
- PH-responsive nanoparticle using mussel adhesive protein for drug delivery and method for preparing the same
- compound, gaba-at activity modulation method, dopamine level modulation method, substance dependence treatment method, ornithine aminotransferase activity modulation method, ornithine aminotransferase activity reduction method expressed by a human hepatocellular carcinoma and method for treating psychological and neurological disorders
- Use of Engrailed Proteins for Increasing Dopamine Synthesis by Dopaminergic Neurons
